par Agathe Masson | Déc 13, 2024 | Access to Care, NCD Solutions, Actualités
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Solutions, Actualités
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide. Between 2010 and 2050, an estimated 14 million babies will be affected globally, with the vast majority born in low- and middle-income countries (LMICs). This staggering...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Policy, Actualités
Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
par Agathe Masson | Déc 9, 2024 | Access to Care, NCD Financing, Actualités
Success in improving access to cancer care is not about a one-size-fits-all approach; it involves addressing unmet needs with high-impact actions. In its comprehensive white paper, Improving Access to Affordable and Sustainable Oncological Care in Africa, IQVIA...
par Callie Weber | Fév 21, 2024 | Behind the Scenes
NCD’s are responsible for 74% of global deaths, and continues to grow. IDA Foundation over 50 years of demonstrated expertise and experience in medical supply chains, delivering to over 130 countries. There is a strong alignment of the global need and our ability to...